170 related articles for article (PubMed ID: 29549642)
1. Computer-Aided Antibody Design: An Overview.
Choong YS; Lee YV; Soong JX; Law CT; Lim YY
Adv Exp Med Biol; 2017; 1053():221-243. PubMed ID: 29549642
[TBL] [Abstract][Full Text] [Related]
2. IsAb: a computational protocol for antibody design.
Liang T; Chen H; Yuan J; Jiang C; Hao Y; Wang Y; Feng Z; Xie XQ
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33876197
[TBL] [Abstract][Full Text] [Related]
3. Computational approaches to therapeutic antibody design: established methods and emerging trends.
Norman RA; Ambrosetti F; Bonvin AMJJ; Colwell LJ; Kelm S; Kumar S; Krawczyk K
Brief Bioinform; 2020 Sep; 21(5):1549-1567. PubMed ID: 31626279
[TBL] [Abstract][Full Text] [Related]
4. Structure-Guided Design of Antibodies.
Caravella JA; Wang D; Glaser SM; Lugovskoy A
Curr Comput Aided Drug Des; 2010; 6(2):128-38. PubMed ID: 26845329
[TBL] [Abstract][Full Text] [Related]
5. Increasing stability of antibody via antibody engineering: stability engineering on an anti-hVEGF.
Wang S; Liu M; Zeng D; Qiu W; Ma P; Yu Y; Chang H; Sun Z
Proteins; 2014 Oct; 82(10):2620-30. PubMed ID: 24916692
[TBL] [Abstract][Full Text] [Related]
6. Computational design of antibodies.
Fischman S; Ofran Y
Curr Opin Struct Biol; 2018 Aug; 51():156-162. PubMed ID: 29791878
[TBL] [Abstract][Full Text] [Related]
7. Rational design of potent mimic peptide derived from monoclonal antibody: antibody mimic design.
Feng J; Li Y; Zhang W; Shen B
Immunol Lett; 2005 May; 98(2):311-6. PubMed ID: 15860233
[TBL] [Abstract][Full Text] [Related]
8. Exploring the potential of global protein-protein docking: an overview and critical assessment of current programs for automatic ab initio docking.
Huang SY
Drug Discov Today; 2015 Aug; 20(8):969-77. PubMed ID: 25801181
[TBL] [Abstract][Full Text] [Related]
9. Optimizing properties of antireceptor antibodies using kinetic computational models and experiments.
Harms BD; Kearns JD; Su SV; Kohli N; Nielsen UB; Schoeberl B
Methods Enzymol; 2012; 502():67-87. PubMed ID: 22208982
[TBL] [Abstract][Full Text] [Related]
10. Analysis of interleukin 23 and 7G10 interactions for computational design of lead antibodies against immune-mediated inflammatory diseases.
Saba Khan N; Verma R; Pradhan D; Nayek A; Bhuyan R; Kumar Sahu T; Kumar Jain A
J Recept Signal Transduct Res; 2018 Aug; 38(4):327-334. PubMed ID: 30481093
[TBL] [Abstract][Full Text] [Related]
11. Probing binding mechanism of interleukin-6 and olokizumab: in silico design of potential lead antibodies for autoimmune and inflammatory diseases.
Verma R; Yadav M; Pradhan D; Bhuyan R; Aggarwal S; Nayek A; Jain AK
J Recept Signal Transduct Res; 2016 Dec; 36(6):601-616. PubMed ID: 26982101
[TBL] [Abstract][Full Text] [Related]
12. Toward rational antibody design: recent advancements in molecular dynamics simulations.
Yamashita T
Int Immunol; 2018 Apr; 30(4):133-140. PubMed ID: 29346652
[TBL] [Abstract][Full Text] [Related]
13. Application of Computational Techniques in Antibody Fc-Fused Molecule Design for Therapeutics.
Ng CL; Lim TS; Choong YS
Mol Biotechnol; 2024 Apr; 66(4):568-581. PubMed ID: 37742298
[TBL] [Abstract][Full Text] [Related]
14. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
15. The coming of age of engineered multivalent antibodies.
Nuñez-Prado N; Compte M; Harwood S; Álvarez-Méndez A; Lykkemark S; Sanz L; Álvarez-Vallina L
Drug Discov Today; 2015 May; 20(5):588-94. PubMed ID: 25757598
[TBL] [Abstract][Full Text] [Related]
16. Computer-Aided Drug Design Methods.
Yu W; MacKerell AD
Methods Mol Biol; 2017; 1520():85-106. PubMed ID: 27873247
[TBL] [Abstract][Full Text] [Related]
17. Computational investigation of inhibitory mechanism of flavonoids as bovine serum albumin anti-glycation agents.
Johari A; Moosavi-Movahedi AA; Amanlou M
Daru; 2014 Dec; 22(1):79. PubMed ID: 25498599
[TBL] [Abstract][Full Text] [Related]
18. Experimentally guided computational antibody affinity maturation with de novo docking, modelling and rational design.
Cannon DA; Shan L; Du Q; Shirinian L; Rickert KW; Rosenthal KL; Korade M; van Vlerken-Ysla LE; Buchanan A; Vaughan TJ; Damschroder MM; Popovic B
PLoS Comput Biol; 2019 May; 15(5):e1006980. PubMed ID: 31042706
[TBL] [Abstract][Full Text] [Related]
19. [Monoclonal antibodies, act two: new molecules for new challenges].
Dutertre CA; Teillaud JL
J Soc Biol; 2006; 200(4):377-86. PubMed ID: 17652973
[TBL] [Abstract][Full Text] [Related]
20. Affinity enhancement of an in vivo matured therapeutic antibody using structure-based computational design.
Clark LA; Boriack-Sjodin PA; Eldredge J; Fitch C; Friedman B; Hanf KJ; Jarpe M; Liparoto SF; Li Y; Lugovskoy A; Miller S; Rushe M; Sherman W; Simon K; Van Vlijmen H
Protein Sci; 2006 May; 15(5):949-60. PubMed ID: 16597831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
